Foravirumab
From Infogalactic: the planetary knowledge core
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | rabies virus glycoprotein |
| Identifiers | |
| CAS Number | 944548-38-3  |
| ATC code | none |
| UNII | 377VY97V7S  |
| ChEMBL | CHEMBL1743021 |
| Chemical data | |
| Formula | C6400H9914N1718O1998S44 |
| Molecular mass | 144.3 kg/mol |
| (what is this?) (verify) |
|
Foravirumab is a monoclonal antibody for the prophylaxis of rabies.[1] It is under development by Sanofi/Crucell.[2]
References
- ↑ International Nonproprietary Names for Pharmaceutical Substances (INN), World Health Organization.
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This antiinfective drug article is a stub. You can help Wikipedia by expanding it. |
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This monoclonal antibody-related article is a stub. You can help Wikipedia by expanding it. |
Categories:
- Chemical articles having calculated molecular weight overwritten
- Drugs that are a monoclonal antibody
- Chemicals that do not have a ChemSpider ID assigned
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs not assigned an ATC code
- Drugs with no legal status
- Monoclonal antibodies
- Antiinfective agent stubs
- Monoclonal antibody stubs
